P Hilgard

434 total citations
6 papers, 309 citations indexed

About

P Hilgard is a scholar working on Hepatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, P Hilgard has authored 6 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 4 papers in Epidemiology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in P Hilgard's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cancer Mechanisms and Therapy (2 papers). P Hilgard is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cancer Mechanisms and Therapy (2 papers). P Hilgard collaborates with scholars based in Germany. P Hilgard's co-authors include Stefan Zeuzem, M. Moscovici, Jean‐Luc Raoul, Josep M. Llovet, Vincenzo Mazzaferro, D. Voliotis, Jordi Bruix, Serafino Ricci, Melanie Poulin-Costello and Gerald Antoch and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Surgeons and Journal of Nuclear Medicine.

In The Last Decade

P Hilgard

6 papers receiving 298 citations

Peers

P Hilgard
Denise N. Gansen United States
Han Qi China
S.M. Ibrahim United States
Joong-Won Park South Korea
Ryu Otao Japan
P Hilgard
Citations per year, relative to P Hilgard P Hilgard (= 1×) peers Robert Bader

Countries citing papers authored by P Hilgard

Since Specialization
Citations

This map shows the geographic impact of P Hilgard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Hilgard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Hilgard more than expected).

Fields of papers citing papers by P Hilgard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Hilgard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Hilgard. The network helps show where P Hilgard may publish in the future.

Co-authorship network of co-authors of P Hilgard

This figure shows the co-authorship network connecting the top 25 collaborators of P Hilgard. A scholar is included among the top collaborators of P Hilgard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Hilgard. P Hilgard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Herzer, Kerstin, et al.. (2011). Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheres.. PubMed. 57(3). 287–98. 2 indexed citations
2.
Antoch, Gerald, Stefan Müeller, M Hamami, et al.. (2010). Selektive interne Radiotherapie (SIRT) beim hepatozellulären Karzinom. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 182(8). 660–670. 5 indexed citations
3.
Hamami, M, Thorsten D. Poeppel, Stephan Müller, et al.. (2009). SPECT/CT with 99mTc-MAA in Radioembolization with 90Y Microspheres in Patients with Hepatocellular Cancer. Journal of Nuclear Medicine. 50(5). 688–692. 74 indexed citations
4.
Sotiropoulos, Georgios C., Hauke Lang, Silvio Nadalin, et al.. (2007). Liver Transplantation for Hepatocellular Carcinoma: University Hospital Essen Experience and Metaanalysis of Prognostic Factors. Journal of the American College of Surgeons. 205(5). 661–675. 41 indexed citations
5.
Llovet, Josep M., Serafino Ricci, Vincenzo Mazzaferro, et al.. (2007). Randomized phase III trial of sorafenib versus placebo in patients with advanced hepatocellular carcinoma (HCC). Journal of Clinical Oncology. 25(18_suppl). LBA1–LBA1. 163 indexed citations
6.
Llovet, Josep M., Vincenzo Mazzaferro, Serena Ricci, et al.. (2007). 3507 ORAL Sorafenib improves survival in a large multi-center, randomized, placebo-controlled phase III trial in patients with hepatocellular carcinoma. European Journal of Cancer Supplements. 5(4). 261–261. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026